Upgrades
For 3M Co (NYSE:MMM), UBS upgraded the previous rating of Sell to Neutral. For the second quarter, 3M had an EPS of $2.48, compared to year-ago quarter EPS of $2.59. The current stock performance of 3M shows a 52-week-high of $181.78 and a 52-week-low of $115.98. Moreover, at the end of the last trading period, the closing price was at $119.27.
Daiwa Capital upgraded the previous rating for Coinbase Global Inc (NASDAQ:COIN) from Outperform to Buy. Coinbase Global earned $4.98 in the second quarter, compared to $6.42 in the year-ago quarter. At the moment, the stock has a 52-week-high of $258.81 and a 52-week-low of $40.83. Coinbase Global closed at $73.08 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
Cleveland Research downgraded the previous rating for Avantor Inc (NYSE:AVTR) from Buy to Neutral. For the second quarter, Avantor had an EPS of $0.37, compared to year-ago quarter EPS of $0.35. At the moment, the stock has a 52-week-high of $41.98 and a 52-week-low of $24.32. Avantor closed at $25.87 at the end of the last trading period.
For Zumiez Inc (NASDAQ:ZUMZ), William Blair downgraded the previous rating of Outperform to Market Perform. In the second quarter, Zumiez showed an EPS of $0.16, compared to $0.94 from the year-ago quarter. The stock has a 52-week-high of $49.98 and a 52-week-low of $24.02. At the end of the last trading period, Zumiez closed at $26.54.
For Sonic Automotive Inc (NYSE:SAH), B of A Securities downgraded the previous rating of Buy to Underperform. Sonic Automotive earned $2.45 in the second quarter, compared to $2.63 in the year-ago quarter. At the moment, the stock has a 52-week-high of $59.19 and a 52-week-low of $34.17. Sonic Automotive closed at $47.83 at the end of the last trading period.
For CarMax Inc (NYSE:KMX), B of A Securities downgraded the previous rating of Neutral to Underperform. For the first quarter, CarMax had an EPS of $1.56, compared to year-ago quarter EPS of $2.63. The stock has a 52-week-high of $130.57 and a 52-week-low of $84.37. At the end of the last trading period, CarMax closed at $88.88.
According to Morgan Stanley, the prior rating for Galapagos NV (NASDAQ:GLPG) was changed from Overweight to Equal-Weight. Galapagos earned $0.31 in the second quarter, compared to $1.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $72.11 and a 52-week-low of $47.88. Galapagos closed at $48.57 at the end of the last trading period.
BTIG downgraded the previous rating for New Fortress Energy Inc (NASDAQ:NFE) from Buy to Neutral. New Fortress Energy earned $0.69 in the second quarter, compared to $0.03 in the year-ago quarter. The stock has a 52-week-high of $63.06 and a 52-week-low of $19.17. At the end of the last trading period, New Fortress Energy closed at $58.79.
B. Riley Securities downgraded the previous rating for Zumiez Inc (NASDAQ:ZUMZ) from Buy to Neutral. In the second quarter, Zumiez showed an EPS of $0.16, compared to $0.94 from the year-ago quarter. At the moment, the stock has a 52-week-high of $49.98 and a 52-week-low of $24.02. Zumiez closed at $26.54 at the end of the last trading period.
See all analyst ratings downgrades.
Initiations
With a Buy rating, DA Davidson initiated coverage on CF Acquisition Corp VI (NASDAQ:CFVI). The price target seems to have been set at $12.00 for CF Acquisition. The stock has a 52-week-high of $18.52 and a 52-week-low of $9.93. At the end of the last trading period, CF Acquisition closed at $12.27.
For Polestar Automotive Holding UK PLC (NASDAQ:PSNY), Redburn Partners initiated coverage, by setting the current rating at Sell. The stock has a 52-week-high of $13.36 and a 52-week-low of $6.17. At the end of the last trading period, Polestar Automotive closed at $6.72.
With a Buy rating, Canaccord Genuity initiated coverage on Rubicon Technologies Inc (NYSE:RBT). The price target seems to have been set at $10.00 for Rubicon Technologies. The stock has a 52-week-high of $7.94 and a 52-week-low of $3.54. At the end of the last trading period, Rubicon Technologies closed at $3.91.
Raymond James initiated coverage on V2X Inc (NYSE:VVX) with a Strong Buy rating. The price target for V2X is set to $50.00. The current stock performance of V2X shows a 52-week-high of $41.25 and a 52-week-low of $29.55. Moreover, at the end of the last trading period, the closing price was at $33.88.
Baird initiated coverage on Swvl Holdings Corp (NASDAQ:SWVL) with an Outperform rating. The price target for Swvl Hldgs is set to $8.00. NoneThe current stock performance of Swvl Hldgs shows a 52-week-high of $11.40 and a 52-week-low of $1.42. Moreover, at the end of the last trading period, the closing price was at $1.54.
With a Buy rating, DA Davidson initiated coverage on Waldencast PLC (NASDAQ:WALD). The price target seems to have been set at $12.00 for Waldencast. The current stock performance of Waldencast shows a 52-week-high of $10.89 and a 52-week-low of $6.56. Moreover, at the end of the last trading period, the closing price was at $8.60.
See all analyst ratings initiations.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
According to Morgan Stanley, the prior rating for Ionis Pharmaceuticals Inc (NASDAQ:IONS) was changed from Underweight to Overweight. Ionis Pharmaceuticals earned $0.56 in the second quarter, compared to $0.26 in the year-ago quarter. The current stock performance of Ionis Pharmaceuticals shows a 52-week-high of $46.15 and a 52-week-low of $28.25. Moreover, at the end of the last trading period, the closing price was at $44.27.
According to B of A Securities, the prior rating for Elevance Health Inc (NYSE:ELV) was changed from Neutral to Buy. Elevance Health earned $8.04 in the second quarter, compared to $7.03 in the year-ago quarter. NoneThe current stock performance of Elevance Health shows a 52-week-high of $512.99 and a 52-week-low of $451.37. Moreover, at the end of the last trading period, the closing price was at $489.35.
For Regeneron Pharmaceuticals Inc (NASDAQ:REGN), Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the second quarter, Regeneron Pharmaceuticals showed an EPS of $9.77, compared to $25.80 from the year-ago quarter. The stock has a 52-week-high of $747.42 and a 52-week-low of $538.01. At the end of the last trading period, Regeneron Pharmaceuticals closed at $708.85.
Morgan Stanley upgraded the previous rating for Hudson Pacific Properties Inc (NYSE:HPP) from Underweight to Equal-Weight. In the second quarter, Hudson Pacific Properties showed an EPS of $0.51, compared to $0.49 from the year-ago quarter. The stock has a 52-week-high of $28.66 and a 52-week-low of $12.73. At the end of the last trading period, Hudson Pacific Properties closed at $14.14.
Needham upgraded the previous rating for Penumbra Inc (NYSE:PEN) from Hold to Buy. For the second quarter, Penumbra had an EPS of $0.01, compared to year-ago quarter EPS of $0.21. The current stock performance of Penumbra shows a 52-week-high of $287.53 and a 52-week-low of $114.86. Moreover, at the end of the last trading period, the closing price was at $197.49.
According to Jefferies, the prior rating for Regeneron Pharmaceuticals Inc (NASDAQ:REGN) was changed from Underperform to Hold. For the second quarter, Regeneron Pharmaceuticals had an EPS of $9.77, compared to year-ago quarter EPS of $25.80. The current stock performance of Regeneron Pharmaceuticals shows a 52-week-high of $747.42 and a 52-week-low of $538.01. Moreover, at the end of the last trading period, the closing price was at $708.85.
According to JP Morgan, the prior rating for Spire Inc (NYSE:SR) was changed from Neutral to Overweight. For the third quarter, Spire had an EPS of $0.01, compared to year-ago quarter EPS of $0.06. The current stock performance of Spire shows a 52-week-high of $79.24 and a 52-week-low of $61.89. Moreover, at the end of the last trading period, the closing price was at $69.59.
JP Morgan upgraded the previous rating for American Water Works Co Inc (NYSE:AWK) from Underweight to Neutral. American Water Works earned $1.20 in the second quarter, compared to $1.14 in the year-ago quarter. NoneThe current stock performance of American Water Works shows a 52-week-high of $189.25 and a 52-week-low of $129.45. Moreover, at the end of the last trading period, the closing price was at $154.52.
For Essential Utilities Inc (NYSE:WTRG), B of A Securities downgraded the previous rating of Buy to Neutral. Essential Utilities earned $0.31 in the second quarter, compared to $0.32 in the year-ago quarter. The current stock performance of Essential Utilities shows a 52-week-high of $53.66 and a 52-week-low of $40.97. Moreover, at the end of the last trading period, the closing price was at $48.66.
According to Guggenheim, the prior rating for Enphase Energy Inc (NASDAQ:ENPH) was changed from Buy to Neutral. In the second quarter, Enphase Energy showed an EPS of $1.07, compared to $0.53 from the year-ago quarter. The current stock performance of Enphase Energy shows a 52-week-high of $324.84 and a 52-week-low of $113.40. Moreover, at the end of the last trading period, the closing price was at $317.41.
For Shoals Technologies Group Inc (NASDAQ:SHLS), Guggenheim downgraded the previous rating of Buy to Neutral. For the second quarter, Shoals Technologies Gr had an EPS of $0.07, compared to year-ago quarter EPS of $0.09. The current stock performance of Shoals Technologies Gr shows a 52-week-high of $28.47 and a 52-week-low of $9.58. Moreover, at the end of the last trading period, the closing price was at $27.60.
For American Axle & Mfg Holdings Inc (NYSE:AXL), B of A Securities downgraded the previous rating of Buy to Neutral. In the second quarter, American Axle & Mfg Hldgs showed an EPS of $0.22, compared to $0.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.96 and a 52-week-low of $6.36. American Axle & Mfg Hldgs closed at $9.87 at the end of the last trading period.
For Navient Corp (NASDAQ:NAVI), Barclays downgraded the previous rating of Overweight to Equal-Weight. For the second quarter, Navient had an EPS of $0.92, compared to year-ago quarter EPS of $0.98. The current stock performance of Navient shows a 52-week-high of $22.59 and a 52-week-low of $12.45. Moreover, at the end of the last trading period, the closing price was at $15.01.
For Prelude Therapeutics Inc (NASDAQ:PRLD), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. For the second quarter, Prelude Therapeutics had an EPS of $0.58, compared to year-ago quarter EPS of $0.58. The current stock performance of Prelude Therapeutics shows a 52-week-high of $13.40 and a 52-week-low of $3.87. Moreover, at the end of the last trading period, the closing price was at $7.94.
Morgan Stanley downgraded the previous rating for Cyteir Therapeutics Inc (NASDAQ:CYT) from Overweight to Equal-Weight. For the second quarter, Cyteir Therapeutics had an EPS of $0.34, compared to year-ago quarter EPS of $4.83. The stock has a 52-week-high of $11.62 and a 52-week-low of $1.55. At the end of the last trading period, Cyteir Therapeutics closed at $2.15.
For Alector Inc (NASDAQ:ALEC), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. In the second quarter, Alector showed an EPS of $0.12, compared to $0.69 from the year-ago quarter. The current stock performance of Alector shows a 52-week-high of $21.25 and a 52-week-low of $7.50. Moreover, at the end of the last trading period, the closing price was at $10.99.
Morgan Stanley downgraded the previous rating for ADC Therapeutics SA (NYSE:ADCT) from Overweight to Equal-Weight. In the second quarter, ADC Therapeutics showed an EPS of $0.73, compared to $0.70 from the year-ago quarter. At the moment, the stock has a 52-week-high of $20.67 and a 52-week-low of $5.52. ADC Therapeutics closed at $6.52 at the end of the last trading period.
For Virgin Galactic Holdings Inc (NYSE:SPCE), Bernstein downgraded the previous rating of Market Perform to Underperform. For the second quarter, Virgin Galactic Hldgs had an EPS of $0.43, compared to year-ago quarter EPS of $0.39. At the moment, the stock has a 52-week-high of $13.73 and a 52-week-low of $5.14. Virgin Galactic Hldgs closed at $6.28 at the end of the last trading period.
JP Morgan downgraded the previous rating for New Jersey Resources Corp (NYSE:NJR) from Neutral to Underweight. New Jersey Resources earned $0.04 in the third quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $47.50 and a 52-week-low of $37.79. New Jersey Resources closed at $45.64 at the end of the last trading period.
Loop Capital initiated coverage on Academy Sports and Outdoors Inc (NASDAQ:ASO) with a Buy rating. The price target for Academy Sports is set to $60.00. Academy Sports earned $2.30 in the second quarter, compared to $2.34 in the year-ago quarter. The current stock performance of Academy Sports shows a 52-week-high of $50.00 and a 52-week-low of $25.10. Moreover, at the end of the last trading period, the closing price was at $48.28.
BTIG initiated coverage on Annexon Inc (NASDAQ:ANNX) with a Buy rating. The price target for Annexon is set to $15.00. Annexon earned $0.96 in the second quarter, compared to $0.82 in the year-ago quarter. The current stock performance of Annexon shows a 52-week-high of $11.95 and a 52-week-low of $2.06. Moreover, at the end of the last trading period, the closing price was at $6.02.
Credit Suisse initiated coverage on Frontier Communications Parent Inc (NASDAQ:FYBR) with a Neutral rating. The price target for Frontier Communications is set to $25.00. The current stock performance of Frontier Communications shows a 52-week-high of $31.86 and a 52-week-low of $21.93. Moreover, at the end of the last trading period, the closing price was at $26.99.
Morgan Stanley initiated coverage on Vir Biotechnology Inc (NASDAQ:VIR) with an Underweight rating. The price target for Vir Biotechnology is set to $15.00. Vir Biotechnology earned $0.58 in the second quarter, compared to $0.46 in the year-ago quarter. At the moment, the stock has a 52-week-high of $41.85 and a 52-week-low of $18.21. Vir Biotechnology closed at $22.26 at the end of the last trading period.
With a Equal-Weight rating, Morgan Stanley initiated coverage on PTC Therapeutics Inc (NASDAQ:PTCT). The price target seems to have been set at $54.00 for PTC Therapeutics. PTC Therapeutics earned $2.13 in the second quarter, compared to $1.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $54.69 and a 52-week-low of $25.01. PTC Therapeutics closed at $53.85 at the end of the last trading period.
Morgan Stanley initiated coverage on Immunocore Holdings PLC (NASDAQ:IMCR) with an Overweight rating. The price target for Immunocore Hldgs is set to $77.00. Immunocore Hldgs earned $0.17 in the second quarter, compared to $1.45 in the year-ago quarter. The stock has a 52-week-high of $57.44 and a 52-week-low of $18.43. At the end of the last trading period, Immunocore Hldgs closed at $57.44.
Morgan Stanley initiated coverage on Halozyme Therapeutics Inc (NASDAQ:HALO) with an Overweight rating. The price target for Halozyme Therapeutics is set to $50.00. Halozyme Therapeutics earned $0.53 in the second quarter, compared to $0.66 in the year-ago quarter. The current stock performance of Halozyme Therapeutics shows a 52-week-high of $52.98 and a 52-week-low of $31.36. Moreover, at the end of the last trading period, the closing price was at $39.67.
With a Equal-Weight rating, Morgan Stanley initiated coverage on Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR). The price target seems to have been set at $41.00 for Arrowhead Pharmaceuticals. For the third quarter, Arrowhead Pharmaceuticals had an EPS of $0.68, compared to year-ago quarter EPS of $0.29. At the moment, the stock has a 52-week-high of $70.09 and a 52-week-low of $26.81. Arrowhead Pharmaceuticals closed at $39.17 at the end of the last trading period.
Morgan Stanley initiated coverage on Amicus Therapeutics Inc (NASDAQ:FOLD) with a Equal-Weight rating. The price target for Amicus Therapeutics is set to $14.00. For the second quarter, Amicus Therapeutics had an EPS of $0.21, compared to year-ago quarter EPS of $0.19. The stock has a 52-week-high of $12.96 and a 52-week-low of $5.91. At the end of the last trading period, Amicus Therapeutics closed at $11.70.
With an Overweight rating, Barclays initiated coverage on Immunogen Inc (NASDAQ:IMGN). The price target seems to have been set at $8.00 for Immunogen. For the second quarter, Immunogen had an EPS of $0.24, compared to year-ago quarter EPS of $0.15. The stock has a 52-week-high of $7.63 and a 52-week-low of $3.10. At the end of the last trading period, Immunogen closed at $5.46.
B of A Securities initiated coverage on Omnicell Inc (NASDAQ:OMCL) with a Buy rating. The price target for Omnicell is set to $120.00. For the second quarter, Omnicell had an EPS of $0.84, compared to year-ago quarter EPS of $0.97. The current stock performance of Omnicell shows a 52-week-high of $182.77 and a 52-week-low of $98.50. Moreover, at the end of the last trading period, the closing price was at $101.82.
Seaport Global initiated coverage on SoFi Technologies Inc (NASDAQ:SOFI) with a Neutral rating. In the second quarter, SoFi Technologies showed an EPS of $0.12, compared to $0.48 from the year-ago quarter. The current stock performance of SoFi Technologies shows a 52-week-high of $16.47 and a 52-week-low of $4.82. Moreover, at the end of the last trading period, the closing price was at $6.19.
Barclays initiated coverage on Arvinas Inc (NASDAQ:ARVN) with an Overweight rating. The price target for Arvinas is set to $90.00. For the second quarter, Arvinas had an EPS of $1.32, compared to year-ago quarter EPS of $1.03. At the moment, the stock has a 52-week-high of $82.86 and a 52-week-low of $34.90. Arvinas closed at $48.42 at the end of the last trading period.
UBS initiated coverage on Horizon Technology Finance Corp (NASDAQ:HRZN) with a Neutral rating. The price target for Horizon Tech Finance is set to $12.50. In the second quarter, Horizon Tech Finance showed an EPS of $0.35, compared to $0.31 from the year-ago quarter. The current stock performance of Horizon Tech Finance shows a 52-week-high of $16.54 and a 52-week-low of $10.55. Moreover, at the end of the last trading period, the closing price was at $12.27.
With a Neutral rating, Rosenblatt initiated coverage on Brightcove Inc (NASDAQ:BCOV). The price target seems to have been set at $8.00 for Brightcove. In the second quarter, Brightcove showed an EPS of $0.10, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $10.52 and a 52-week-low of $5.84. Brightcove closed at $6.75 at the end of the last trading period.
With a Buy rating, Rosenblatt initiated coverage on Lincoln Educational Services Corp (NASDAQ:LINC). The price target seems to have been set at $8.00 for Lincoln Educational Servs. In the second quarter, Lincoln Educational Servs showed an EPS of $0.00, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $7.95 and a 52-week-low of $4.94. At the end of the last trading period, Lincoln Educational Servs closed at $6.48.
Rosenblatt initiated coverage on Quotient Technology Inc (NYSE:QUOT) with a Neutral rating. The price target for Quotient Technology is set to $3.50. In the second quarter, Quotient Technology showed an EPS of $0.45, compared to $0.18 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.92 and a 52-week-low of $1.68. Quotient Technology closed at $1.85 at the end of the last trading period.
Piper Sandler initiated coverage on Inter Parfums Inc (NASDAQ:IPAR) with an Overweight rating. The price target for Inter Parfums is set to $102.00. For the second quarter, Inter Parfums had an EPS of $0.86, compared to year-ago quarter EPS of $0.71. The stock has a 52-week-high of $108.35 and a 52-week-low of $64.52. At the end of the last trading period, Inter Parfums closed at $78.30.
With a Hold rating, Jefferies initiated coverage on Progress Software Corp (NASDAQ:PRGS). The price target seems to have been set at $52.00 for Progress Software. For the second quarter, Progress Software had an EPS of $1.04, compared to year-ago quarter EPS of $0.82. The stock has a 52-week-high of $51.77 and a 52-week-low of $41.68. At the end of the last trading period, Progress Software closed at $46.67.
